Pliant Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pliant Therapeutics, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 3.0 times its market value (net cash). Higher than 97% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-77.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 79% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -36%In 3 years sales changed by -100% while total assets changed by -36%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-88.7×Operating cash was negative last year, while some debt falls due within a year.
Lower than 81% of Healthcare companies in United States.
Cash Cushion Ratio
3.0× cashCash, after subtracting all debt, is 3.0 times its market value (net cash).
Higher than 97% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Pliant Therapeutics, Inc. made a loss over the last year. Pliant Therapeutics, Inc. owes $0.23 for every $1 it owns. Pliant Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPliant Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.36The share price is 0.36 times Pliant Therapeutics, Inc.'s book value per share, lower than 94% of Healthcare companies in United States.
Market cap
$53 MThe total market value of all of Pliant Therapeutics, Inc.'s shares at today's price (share price × number of shares), smaller than 73% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$147 MWhat Pliant Therapeutics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.37Net worth divided by the number of shares. The share price of $0.86 is 0.4 times this, which is the P/B above.
Return on equity (ROE)
-50.3%Pliant Therapeutics, Inc. lost 50.3% of its shareholders' money over the last year, lower than 51% of Healthcare companies in United States.
Owes vs Owns
0.23×Pliant Therapeutics, Inc. owes $0.23 for every $1 it owns (low), lower than 70% of Healthcare companies in United States.
Dividend yield
NonePliant Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossPliant Therapeutics, Inc. made a loss in each of the last two years.
Interest cover
Not coveredPliant Therapeutics, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashPliant Therapeutics, Inc. held $162 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pliant Therapeutics, Inc.: $53 M ÷ $147 M (30 Jun 2026) = 0.4.
What is Pliant Therapeutics, Inc.'s return on equity?
Pliant Therapeutics, Inc. lost 50.3% of its shareholders' money over the last year, lower than 51% of Healthcare companies in United States.
How much does Pliant Therapeutics, Inc. owe compared with what it owns?
Pliant Therapeutics, Inc. owes $0.23 for every $1 it owns (low), lower than 70% of Healthcare companies in United States.
Does Pliant Therapeutics, Inc. pay a dividend?
No. Pliant Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.